129 related articles for article (PubMed ID: 20708732)
1. Genetic variation in complement factor H and risk of coronary heart disease: eight new studies and a meta-analysis of around 48,000 individuals.
Sofat R; Casas JP; Kumari M; Talmud PJ; Ireland H; Kivimaki M; Marmot M; Hughes AD; Thom S; Ebrahim S; Whittaker JC; Smeeth L; Lawlor DA; Humphries SE; Hingorani AD
Atherosclerosis; 2010 Nov; 213(1):184-90. PubMed ID: 20708732
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
[TBL] [Abstract][Full Text] [Related]
3. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
[TBL] [Abstract][Full Text] [Related]
4. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.
Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Soheilian M
Acta Ophthalmol; 2018 Mar; 96(2):e105-e110. PubMed ID: 28593728
[TBL] [Abstract][Full Text] [Related]
5. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
[TBL] [Abstract][Full Text] [Related]
6. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.
Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis.
Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Nazari R; Soheilian M
Int Ophthalmol; 2019 Apr; 39(4):949-956. PubMed ID: 29423786
[TBL] [Abstract][Full Text] [Related]
8. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
[TBL] [Abstract][Full Text] [Related]
9. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women.
Pai JK; Manson JE; Rexrode KM; Albert CM; Hunter DJ; Rimm EB
Eur Heart J; 2007 Jun; 28(11):1297-303. PubMed ID: 17483111
[TBL] [Abstract][Full Text] [Related]
10. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.
Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M
Int Ophthalmol; 2017 Dec; 37(6):1397-1409. PubMed ID: 28005184
[TBL] [Abstract][Full Text] [Related]
11. Complement factor H Y402H gene polymorphism and coronary heart disease susceptibility: a meta-analysis.
Zhang HF; Wang JF; Wang Y; Zhu LG; Lei L
Mol Biol Rep; 2011 Jun; 38(5):2933-8. PubMed ID: 20127520
[TBL] [Abstract][Full Text] [Related]
12. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M
Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095
[TBL] [Abstract][Full Text] [Related]
13. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
[TBL] [Abstract][Full Text] [Related]
14. Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis.
Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M; Karimi S
Curr Eye Res; 2016 Dec; 41(12):1519-1525. PubMed ID: 27269047
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis.
Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y
Sci Rep; 2015 Sep; 5():14517. PubMed ID: 26411831
[TBL] [Abstract][Full Text] [Related]
16. CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye.
Wang JC; Cao S; Wang A; To E; Law G; Gao J; Zhang D; Cui JZ; Matsubara JA
Mol Vis; 2015; 21():264-72. PubMed ID: 25814824
[TBL] [Abstract][Full Text] [Related]
17. Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis.
Hong N; Shen Y; Yu CY; Wang SQ; Tong JP
Acta Ophthalmol; 2016 Jun; 94(4):334-45. PubMed ID: 27151934
[TBL] [Abstract][Full Text] [Related]
18. Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population.
Soysal Y; Inan UÜ; Küsbeci T; Imirzalioğlu N
DNA Cell Biol; 2012 Mar; 31(3):323-30. PubMed ID: 21790300
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration.
Thakkinstian A; Han P; McEvoy M; Smith W; Hoh J; Magnusson K; Zhang K; Attia J
Hum Mol Genet; 2006 Sep; 15(18):2784-90. PubMed ID: 16905558
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ
Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
